Table 3 Clinical characteristics of the participants
From: Impact of COVID-19 on mental health of health care workers in Spain: a mix-methods study
| Â | n | % |
|---|---|---|
Depression | ||
 In the past | 69 | 21.6 |
 Currently | 22 | 6.9 |
Anxiety | ||
 In the past | 97 | 30.4 |
 Currently | 92 | 28.8 |
Other psychological problem | ||
 In the past | 20 | 6.3 |
 Currently | 11 | 3.4 |
How do you sleep? | ||
 Worse than before | 207 | 65.1 |
 As usual | 104 | 32.7 |
 Better than before | 7 | 2.2 |
 Psychoactive drugs consumption before the pandemic (yes) | 58 | 18.2 |
Type of psychoactive drugs | ||
 Antidepressant | 18 | 31.0 |
 Anxiolytic | 22 | 37.9 |
 Hypnotic | 8 | 13.8 |
 Others | 10 | 16.4 |
 Extra psychoactive drugs consumption during the pandemic (yes) | 84 | 27.7 |
Effect sought in extra psychoactive drugs | ||
 Hypnotic | 53 | 62.4 |
 Anxiolytic | 31 | 36.5 |
 Others | 1 | 1.2 |
Psychological distress (GHQ-28) | ||
 With psychological distress | 176 | 55.2 |
 Without psychological distress | 143 | 44.8 |
PTSD symptoms (DTS) | ||
 With PTSD symptoms | 89 | 27.9 |
 Without PTSD symptoms | 230 | 72.1 |